insights_auto
Why is LIMN down 10.68%?
Dive Deeperchevron_right
LIMN:NASDAQ
Liminatus Pharma Inc
$2.51
arrow_downward
-10.68%(-0.30) 1D
$2.66
arrow_upward
+5.98% (+0.15)bedtimeAfter hours
Closed: Nov 20, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LIMN...
Open
$2.83
High
$2.98
Low
$2.51
Mkt. cap
3.37M
Avg. vol.
29.33K
Volume
61.86K
52-wk high
$141.50
52-wk low
$2.40
EPS
-$30.59
Beta
0.81
Shares outstanding
1.34M
No. of employees
1
Open
$2.83
High
$2.98
Low
$2.51
Mkt. cap
3.37M
Avg. vol.
29.33K
Volume
61.86K
52-wk high
$141.50
52-wk low
$2.40
EPS
-$30.59
Beta
0.81
Shares outstanding
1.34M
No. of employees
1
News stories
From web sources and news partners
Benzinga
·
1 day ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Investing.com UK
·
3 days ago
Liminatus Pharma appoints Eric Sunghee Kang as chief corporate strategist By Investing.com
Investing.com UK
·
3 days ago
Form 8K Liminatus Pharma Inc For: 18 November By Investing.com
About Liminatus Pharma Inc
CEO-
Employees1
Founded-
HeadquartersCerritos, California, United States
SectorHealth Care
IndustryBiotechnology
Websiteliminatuspharma.com